Clinical

• Amber Vcfix spinal system shows promising data

  Orthopedics

  Amber Implants BV reported no device-related adverse events were seen in any of the patients fitted with its Vcfix spinal system, which treats vertebral compression fractures, at one-year. Data from the first-in-human trial of the device also...

• Rising obesity levels spur endoscopic sleeve uptick

  Obesity

  While GLP-1 receptor agonists continue to grab the headlines as a treatment option for obesity, another therapy, endoscopic sleeve gastroplasty (ESG), is seeing a steady rise in demand.

• It’s time for more trust in AI, panel says

  Conferences

  Despite the advancement of AI and machine learning technologies and their incorporation into cancer treatment and drug development, a lack of trust and understanding of these new approaches is impeding care and treatment.

• Redemption for Lyra as second phase III rhinosinusitis trial hits goal

  Inflammatory

  Shares of Lyra Therapeutics Inc. soared more than 310% on data from its second phase III trial testing drug-device candidate LYR-210 in patients with chronic rhinosinusitis, with results from the Enlighten 2 study showing statistical significance...

• FDA greenlights Distalmotion’s Dexter for gallbladder removal

  Regulatory

  The U.S. FDA granted 510(k) clearance to Distalmotion SA's Dexter, its surgical robotic system, for use in cholecystectomy in adults. The greenlight from the regulatory body is the second nod Dexter has received following de novo clearance granted...

• In TAVR setback, Boston Sci pulls plug on Acurate valves

  Cardiovascular

  Boston Scientific Corp. reported the latest setback in its transcatheter aortic valve replacement (TAVR) aspirations with the news that it is officially discontinuing worldwide sales of its Acurate neo2 and Acurate Prime systems